<code id='8CB8025A13'></code><style id='8CB8025A13'></style>
    • <acronym id='8CB8025A13'></acronym>
      <center id='8CB8025A13'><center id='8CB8025A13'><tfoot id='8CB8025A13'></tfoot></center><abbr id='8CB8025A13'><dir id='8CB8025A13'><tfoot id='8CB8025A13'></tfoot><noframes id='8CB8025A13'>

    • <optgroup id='8CB8025A13'><strike id='8CB8025A13'><sup id='8CB8025A13'></sup></strike><code id='8CB8025A13'></code></optgroup>
        1. <b id='8CB8025A13'><label id='8CB8025A13'><select id='8CB8025A13'><dt id='8CB8025A13'><span id='8CB8025A13'></span></dt></select></label></b><u id='8CB8025A13'></u>
          <i id='8CB8025A13'><strike id='8CB8025A13'><tt id='8CB8025A13'><pre id='8CB8025A13'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:8
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          ALS advocates say criticism of new drugs misses bigger picture
          ALS advocates say criticism of new drugs misses bigger picture

          BrianWallachandSandraAbrevayaofIAmALSspokewithreporterDamianGardeattheSTATFutureSummit.STATAdiagnosi

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Covid hospitalizations on the rise, Humana says

          MoreolderadultshavebeenhospitalizedforCovid-19overthepastseveralweeks,accordingtodatareviewedbyhealt